全天麻胶囊联合氟桂利嗪治疗前庭性偏头痛的临床效果分析  

Clinical effect analysis of Quantianma capsules combined with Flunarizine in treatment of vestibular migraine

作　　者：陈丹 CHEN Dan(Panjin Central Hospital,Panjin Liaoning 124010,China)

机构地区：[1]盘锦市中心医院,辽宁盘锦124010

出　　处：《中国民康医学》2018年第21期82-83,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:回顾性分析全天麻胶囊联合氟桂利嗪治疗前庭性偏头痛的临床疗效。方法:选取92例前庭性偏头痛患者,根据患者就诊先后顺序分为对照组和观察组各46例,观察组口服氟桂利嗪联合全天麻胶囊进行治疗,对照组单纯采用口服氟桂利嗪进行治疗。比较分析两组患者治疗前后眩晕障碍量表(DHI)评分、疼痛视觉评分(VAS)及临床疗效。结果:观察组总有效率高达93.48%,明显高于对照组的78.26%;两组患者眩晕的发作次数、持续时间、DHI评分及VAS评分较治疗前有所改善,且观察组改善更明显,比较差异均有统计学意义(P<0.05)。结论:全天麻胶囊联合氟桂利嗪治疗前庭性偏头痛效果显著优于单纯采用氟桂利嗪,安全性高。Objective： To retrospectively analyze clinical efficacy of Flunarizine combined with Quantianma capsules in treatment of vestibular migraine. Methods： 92 patients with vestibular migraine were enrolled. According to the visit order, they were divided into control group and the observation, 46 cases in each. The observation group was treated with oral Flunarizine combined with Quantianma capsules, while the control group was treated with single oral Flunarizine. The Dizziness Handicap Inventory（DHI） score, visual analogue scale（VAS） score and clinical efficacy were compared between the two groups before and after the treatment. Results： The total effective rate of the observation group was as high as 93.48%, which was significantly higher than that of the control group（78.26%）. The numbers of vertigo, duration, DHI scores and VAS scores in both groups were improved compared with those before the treatment, while the improvement in the observation group was more obvious, and the difference was statistically significant（P〈0.05）. Conclusions： Flunarizine combined with Quantianma capsules in the treatment of vestibular migraine is superior to single Flunarizine with high safety..

关 键 词：前庭性偏头痛 氟桂利嗪 全天麻胶囊 

分 类 号：R255.3[医药卫生—中医内科学]